For the first time in a decade, the American Heart Association and American Stroke Association issued new recommendations for preventing strokes.

A recent study revealed that weight loss medications like Ozempic and Mounjaro might help individuals battling addiction. The findings, published in the scientific journal Addiction, said that people with alcohol addiction who were prescribed these medications had a 50 per cent lower rate of binge drinking compared to those who were not.

A recent study found significant reductions in opioid overdose and alcohol misuse among people taking GLP-1 drugs like Ozempic.

While Ozempic’s weight loss benefits are widely touted, the conversation is increasingly shifting toward its side effects. Commonly reported issues include: nausea, constipation and “Ozempic face,” a condition where rapid weight loss leads to a gaunt appearance.

Weight loss drugs have risen in popularity in the recent years, but a disconnect remains between those who need the drugs and those who can afford to buy them. Drugs like Ozempic, which isn’t available in New Zealand,

What health experts think of the growing Ozempic “microdosing” trend that claims taking very small doses of GLP-1 drugs can still help people lose weight with fewer side effects at a lower cost.